Using both syngeneic and genetically engineered mouse models of HNSCC, the study demonstrated that NSD1 loss leads to immune exclusion and impaired interferon signaling, specifically through the silencing of key innate immune genes such as interferon lambda receptor 1 (IFNLR1). The gene discussed is NSD1; the disease is head and neck squamous cell carcinoma.